Future of Metastatic Bladder Cancer Lies in Combination Immunotherapy, Expert Says – Targeted Oncology
Targeted Oncology |
Future of Metastatic Bladder Cancer Lies in Combination Immunotherapy, Expert Says
Targeted Oncology When combined with other agents, immunotherapy has been shown to provide an additional benefit for patients with bladder cancer, explains Arjun Balar, MD. For example, in the ongoing phase I/II KEYNOTE-037/ECHO-202 study, the combination of … Frontline Immunotherapy in Advanced Bladder Cancer |
